Pressmeddelande

BioStock: Curasight CEO: “Working on accelerated plan for uTREAT”

Cision Publicerad: 28 Nov 2023 09:15

Looking back at the third quarter, it’s clear that Curasight is keeping the momentum in the development. Among other things, the much-anticipated phase II results in brain cancer were presented at the World Molecular Imaging Congress. The company now look forward to more results, while filing applications for further studies with both uTRACE and uTREAT. BioStock contacted Curasight’s CEO Ulrich Krasilnikoff to learn more.

Read the full article at biostock.se:

https://www.biostock.se/en/2023/11/curasight-ceo-working-on-accelerated-plan-for-utreat/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Nyheter om Curasight

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!